Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

Expert Event DayOneBasel on Mental Health

92 views

Published on

How can digital bridge the mental health gaps?
Mental health is a story of gaps. This was made clear by all the speakers and panelists at DayOne’s most recent Expert Meeting titled “Measuring the Unmeasurable - will digital pave the way for new treatments in mental health?” which took place in Basel. Check out the slides from the event here.

Published in: Health & Medicine
  • Be the first to comment

  • Be the first to like this

Expert Event DayOneBasel on Mental Health

  1. 1. DayOne Experts, February 18th, Halle 7, Basel Measuring the Unmeasurable will digital pave the way for new treatments in mental health?
  2. 2. Thomas Brenzikofer, Co-Founder DayOne Manager Networks & Events, BaselArea.swiss
  3. 3. #DayOneBasel
  4. 4. An initiative managed by BaselArea.swiss in close collaboration with the Canton of Basel-Stadt.
  5. 5. Core Team Alain Bindels Roche Andre Moeri Impact Hub Basel Andreas Wicki Kantonsspital Baselland Bejal Joshi T4 Communications Bhupinder Bhullar Consultant Bram Stieltjes University Hospital Basel Christian Bosshard CSEM Christian Schneider University Basel Douglas Haggstrom BaselArea.swiss Enkelejda Miho FHNW Erik Schkommodau FHNW Fabian Streiff BaselArea.swiss Frank Kumli BaselArea.swiss Laurenz Baltzer Karger Publishing Melissa Penny Swiss TPH Michael Rebhan Novartis Nicole Probst- Hensch Swiss TPH Peter Groenen Idorsia Thomas Brenzikofer BaselArea.Swiss Torsten Schwede Swiss Personalised Health Network Viktor Bullain Global coach Andrea Huber- Brösamle ETH Zurich Dr. Niko Beerenwinkel ETH Zürich, D-BSSE Rocco Falchetto President Swiss Society for Porphyria
  6. 6. MANAGED BY SUPPORTING PARTNERS KNOWLEDGE PARTNERS IN CLOSE COLLABORATION WITH DayOne Partners Public and Industry
  7. 7. 7 A growing community of 1500+ healthcare innovators…
  8. 8. 8 working together to shape the future of health
  9. 9. To create a world-leading hub for healthcare innovation, built on the strength of the Basel region respected for its impact and collaboration across disciplines and industries with a focus on precision medicine – the convergence of diagnostics, treatment and digital health. Our Mission and Vision 9
  10. 10. 10
  11. 11. shaping the future of health
  12. 12. Mental Health
  13. 13. “It’s complicated”
  14. 14. self reported
  15. 15. eminence based
  16. 16. face to face
  17. 17. mental health markers
  18. 18. evidence based
  19. 19. self care
  20. 20. social environment behavioural patternsearly intervention
  21. 21. Mental Health Challenges - data: access, quality, standards - privacy - validation of mental health markers - patient adoption, trust, value - patient relevant outcomes - ethical implication
  22. 22. Agenda 18.30 Welcome and Introduction 18:40 Presentations by: Prof. Dr. Gunther Meinlschmidt, University Hospital Basel Nuria Pastor Hernández, Humanitcare, Barcelona Christian Vogler, Advancience, Basel Farina Schurzfeld, Selfapy, Berlin Bear Matthews, Astra Labs, San Francisco 19:30 Panel discussion with speakers joined by Stefan Germann, Fondation Botnar 20:15 Wrap-up and networking with refreshments
  23. 23. Presentations Prof. Dr. Gunther Meinlschmidt Research Director, Dept. of Psychosomatic Medicine, University Hospital Basel
  24. 24. Digital Mental Health Measuring the Unmeasurable – will digital pave the way for new treatments in mental health? D a y O n e E x p e r t s F e b - 1 8 - 2 0 2 0 P r o f . G u n t h e r M e i n l s c h m i d t
  25. 25. Outline D i g i t a l m e n t a l h e a l t h O v e r v i e w o f t h e f i e l d o f d i g i t a l m e n t a l h e a l t h W h y d i g i t a l m e n t a l h e a l t h m a t t e r s … G o a l s , c h a l l e n g e s & o u t l o o k Slide 2
  26. 26. Global burdenGlobal burden of disease in children & adolescents InstituteforHealthMetricsandEvaluation GBD2017–©2020UniversityofWashington G l o b a l e s t i m a t e s 1 9 9 0 – 2 0 1 7 ; 1 0 – 2 4 y e a r s ; D i s a b i l i t y A d j u s t e d L i f e Y e a r s ( D A L Y s ) Slide 3
  27. 27. Slide 4 CostsCosts of “brain” disorders Olesenetal.2012 C o s t s o f D i s o r d e r s o f t h e B r a i n i n E u r o p e – i n b i l l i o n € P P P 2 0 1 0
  28. 28. Global burdenHigh burden – low assistance InstituteforHealthMetrics andEvaluation2015 D e v e l o p m e n t a s s i s t a n c e f o r h e a l t h p e r a r e a a s a p e r c e n t a g e o f t o t a l ( U S $ 3 7 2 . 2 b i l l i o n ) f r o m 2 0 0 0 t o 2 0 1 4 Slide 5
  29. 29. Mental health Physical health Slide 6
  30. 30. Causality?Mental-somatic multimorbidity (II) Tegethoffetal.2016 A d j u s t e d d i s c r e t e - t i m e p r o p o r t i o n a l h a z a r d m o d e l s ( h a z a r d r a t i o s ) N = 6 4 8 3 ; 1 3 – 1 8 y e a r s Slide 7
  31. 31. ComplexityThe challenge C o m p l e x i t y a n d h e t e r o g e n e i t y o f m e n t a l d i s o r d e r s Mental disorders are part of the “complex diseases” that lag behind with regard to our understanding of pathology and highly effective treatments. They represent one of the great challenges for our current health system and beyond… M e n t a l d i s o r d e r s a r e c o m p l e x d i s e a s e s … Science:26APRIL2002;VOL296,ISSUE5568 [Photoillustration:AnnCutting] Slide 8
  32. 32. Bio to DigitalTom Insel N I M H è G o o g l e / V e r i l y è M i n d s t r o n g Anewparadigm–anewhype? Slide 9
  33. 33. Challenge: Develop mobile and IT technologies (such as telemedicine) to increase access to evidence-based care G o a l C : I m p r o v e t r e a t m e n t a n d e x p a n d a c c e s s t o c a r e Grand Challenges in Global Mental Health C o l l i n s e t a l . 2 0 1 1 , N a t u r e Slide 10
  34. 34. Outline D i g i t a l m e n t a l h e a l t h O v e r v i e w o f t h e f i e l d o f d i g i t a l m e n t a l h e a l t h W h y d i g i t a l m e n t a l h e a l t h m a t t e r s … Slide 11
  35. 35. LandscapeDigital mental health T h e l a n d s c a p e o f Notexclusive… EMA/EMI,ecologicalmomentaryassessment/intervention AI,artificialintelligence;DL/ML,deep/machinelearning Slide 12
  36. 36. Digital phenotyping D i a g n o s t i c s – p r e v e n t i o n Ecological momentary assessment (EMA) S m a r t p h o n e / w e a r a b l e s Sensors, voice/communication, social media (“social exhale”) A c t i v e / p a s s i v e ( s e n s o r s ) Recovery, relapse S u i c i d e / b i p o l a r / s c h i z o p h r e n i a Slide 13
  37. 37. DigitalDigital pheno- typing Torousetal.2017 B l e n d e d b i o s e n s o r s ? Slide 14
  38. 38. DigitalDigital pheno- typing Hyo-IlJung,SchoolofMechanical Engineering,YonseiUniversity B l e n d e d b i o s e n s o r s ? Choietal.2014 Colorimetric Lateral Flow Assay Slide 15
  39. 39. The dinosaurOnline psycho- therapy ‘ F r o m F 2 F t o d i g i t a l ’ ; ‘ S k e u o m o r p h s ’ ? F2F,face-to-face ” H u m a n s u b j e c t i n t h e l o o p ” ( s u p e r v i s e d / g u i d e d i n t e r v e n t i o n ) i n c r e a s e s e f f i c a c y è “ H i g h T e c h & H i g h T o u c h ” Slide 16
  40. 40. Peer to peerPeer support: receive & give 7Cups–Curatio–Panoply/koko T h e ‘ A i r B n B ’ o f m e n t a l h e a l t h c a r e ? Slide 17
  41. 41. Smartphone/ mobile interventions (EMIs) M o b i l e m e n t a l h e a l t h EMI,ecologicalmomentaryintervention CBT,cognitivebehavioraltherapy Slide 18
  42. 42. Smartphone/mobile interventions (EMIs) M o b i l e m e n t a l h e a l t h EMI,ecologicalmomentaryintervention CBT,cognitivebehavioraltherapy • Effect-size for anxiety: EMI vs. active control: Hedge’s g: 0.19, p = 0.003 • Effect-size for depression: EMI vs. active control: Hedge’s g: 0.22, p < 0.001 E M I s s h o w e f f i c a c y ( F i r t h e t a l . 2 0 1 7 a , b ) Out of 73 top-ranking mental health apps: • 44% make effectiveness claims (mostly CBT) • 2 apps referring to low-quality evidence • 1 app includes citation to published literature M e n t a l h e a l t h a p p s i n u s e a r e m a r g i n a l l y s u p p o r t e d b y e v i d e n c e ( L a r s e n e t a l . 2 0 1 9 ) Potential factors • Immersion • Placebo / expectancies C h a l l e n g e : t o k e e p p e o p l e i n v o l v e d Slide 19
  43. 43. Gaming cures Gamification / serious games Measeurement-basedhealthcare T h e e x p e r t s o f i m m e r s i o n Slide 20
  44. 44. Artificial intelligence, deep/machine learning B i g d a t a – s m a l l d a t a AI,artificialintelligence;DL/ML,deep/machinelearning A d d r e s s i n g c o m p l e x i t y & h e t e r o g e n e i t y S u p e r v i s e d A I / t h e o r y - b a s e d / - i n f o r m e d ? Slide 21
  45. 45. Master clinicians?AI classics: images, voice, text Ewbanketal.2019 W h e r e i s A I / D L / M L p o w e r f u l ? Slide 22
  46. 46. Slide 23 Pre & Post: MDBF Master clinicians?ML to predict mood changes following EMIs Meinlschmidtetal.2019 EMI,ecologicalmomentaryintervention ML,machinelearning W h e r e i s A I / D L / M L p o w e r f u l ? Mindfulness Emotional imagery Contemplative repetition Facial expression A c c u r a c y M a t t h e w s c o r r e l a t i o n c o e f f i c i e n t P o s i t i v e p r e d i c t i v e v a l u e i n i t i a l r e s p o n s e r a t e ( 4 2 . 3 % )
  47. 47. Master clinicians? Clinical decision support tool Measeurement-basedhealthcare L e a r n i n g h e a l t h - c a r e s y s t e m / c l o s e d l o o p s t e p p e d c a r e Slide 24
  48. 48. Deep learningClinical decision support tool Meinlschmidtetal.unpublished H i g h t e c h – h i g h t o u c h A r t i f i c i a l I n t e l l i g e n c e ( A I ) E x p l a i n a b l e A r t i f i c i a l I n t e l l i g e n c e ( X A I ) S h a r a b l e A r t i f i c i a l I n t e l l i g e n c e ( S h A I ) Slide 25
  49. 49. Digital risksDigital: solution or problem? Meinlschmidtetal.submitted E x a m p l e s : I n t e r n e t g a m i n g d i s o r d e r ; A u t o m a t o p h o b i a Slide 26
  50. 50. Outline D i g i t a l m e n t a l h e a l t h O v e r v i e w o f t h e f i e l d o f d i g i t a l m e n t a l h e a l t h W h y d i g i t a l m e n t a l h e a l t h m a t t e r s … G o a l s , c h a l l e n g e s & o u t l o o k Slide 27
  51. 51. Should we? P l u r a l i s t i c c o n s i d e r a t i o n s Some people may prefer F2F-therapy; others may prefer online therapies, and others a mixture… è Responding to patient preferences. Meinlschmidt&Tegethoff,2017 H o w “ d i g i t a l ” s h o u l d w e g e t i n m e n t a l h e a l t h c a r e ? C a p a c i t y & a v a i l a b i l i t y It’s not about, “How many human mental health care specialists do we want”?, but rather “How many are available?” è Opportunity to reach out to patients without service access. (worldwide) U t i l i t a r i a n r e a s o n s It’s all an (empiric) matter of quality, efficacy, effectiveness, efficiency (time & costs)… S a f e t y , p r i v a c y & r e s p o n s i b i l i t y There is a need of someone taking over responsibility for safety (e.g., harm/suicide) and privacy of services. H u m a n i s t i c c o n s i d e r a t i o n s Access to healthcare, including mental healthcare as basic human right. Constitutive aspect of healthcare is its provision by a human being. è Cf., care of the elderly by robots? Lines of argumentation Slide 28
  52. 52. Integrate? Feasibility Efficacy Engagement Effectiveness Efficiency (time, money) Value Empowerment of patients and families Trust (privacy, agency, transparency) Fairness Responsibility Scalability Revenue / Return on investment Goalsof going digital in the field of mental health T h e c u r r e n t f i e l d i s c h a r a c t e r i z e d b y m a n y p l a y e r s w i t h m a n y s c a t t e r e d g o a l s … “ W e s t i l l h a v e – I t h i n k – m u c h m o r e e x c i t e m e n t t h a n r e s u l t s ” ( T o m I n s e l , 2 0 1 9 , t a l k i n g a b o u t d i g i t a l m e n t a l h e a l t h ) Slide 29
  53. 53. Take home… K e y m e s s a g e s • Suffering and negative impact is devastating • High relevance also in the context of physical disease M e n t a l h e a l t h i s a g r a n d c h a l l e n g e Broad field, ready to mature; yet still in rather early days (“still more excitement than results”) D i g i t a l m e n t a l h e a l t h i s p r o m i s i n g Hampering the value for patients and the society M a n y s c a t t e r e d g o a l s & p e r s p e c t i v e s Slide 30
  54. 54. Outlook & needs D i g i t a l m e n t a l h e a l t h T e a m i n g u p o f s p e c i a l i s t s & i n t e g r a t e g o a l s è S u s t a i n a b l e e m p o w e r m e n t & v a l u e f o r p a t i e n t s C o n s i d e r , f o c u s a n d a d a p t t o t a r g e t p o p u l a t i o n ( e . g . c h i l d r e n & a d o l e s c e n t s ) & h e a l t h c a r e s e t t i n g N e w w a y s t o m e r g e d i g i t a l a n d c l a s s i c a l a p p r o a c h e s ( e . g . S h a r a b l e A I ) è “ H i g h t e c h & h i g h t o u c h ” Slide 31
  55. 55. Thankstoall collaborators • Jong-Hwan Lee & team • Seung-Schik Yoo & team • Hyo-Il Jung & team • Esther Stalujanis • Angelo Belardi • Marion Tegethoff • Noa Naa-Wansa Römmel • …Slide 32
  56. 56. Work only possible with you… Thank you… … to all participants; … to the funding agencies: • Swiss National Science Foundation • Korea Research Foundation (KRF) – Global Research Network Program • Swiss Cancer League • Stanley Thomas Johnson Foundation & Gottfried und Julia Bangerter-Rhyner- Foundation • Research Funds, University of Basel • IPU Berlin Foundation A c k n o w l e d g e m e n t s Slide 33
  57. 57. Digital Mental Health Measuring the Unmeasurable – will digital pave the way for new treatments in mental health? D a y O n e E x p e r t s F e b - 1 8 - 2 0 2 0 P r o f . G u n t h e r M e i n l s c h m i d t
  58. 58. Presentations Nuria Pastor Hernández CEO and Founder Humanitcare, Barcelona
  59. 59. T Cohen, A. B., & Mathews, S. C. (2018). The digital outcome measure. Digital Biomarkers, 2(3), 94-105.1.
  60. 60. REAL-TIME DATA FOR CHRONIC DISEASES Monitoring the raw data of chronic diseases as: -Sleep Data -Activity Data -Time-Reaction Data -Heart Rate Data -Sociability Data -Cognitive Data
  61. 61. Evidence based digital phenotype and digital biomarkers in neuroscience The emerging field of biosensors and wearables, which aims to capture many types of health data, holds promise to specifically capture outcomes while complementing existing outcome collection methods.
  62. 62. Neuroscience and digital phenotype Pilot Study in Mental Health Diseases with Digital Phenotype Unicentric, case-controlled, longitudinal, evaluational, national study with two groups. One control of healthy individuals without symptoms of anxiety or depression. Experimental group in which participants fulfill the given selection criteria for the trial. 60 participants.
  63. 63. Neuroscience and digital phenotype Study in Mental Health Diseases with Digital Phenotype
  64. 64. Neuroscience and digital phenotype Study in Mental Health Diseases with Digital Phenotype, some results (1): Physical Activity
  65. 65. Neuroscience and digital phenotype Study in Mental Health Diseases with Digital Phenotype some results (2): Time of Asleep
  66. 66. Neuroscience and digital phenotype European Study in Irritable Bowel Syndrom and Mental Health and Psyhomatic diseases Goal: to determine mechanisms of intestinal and central nervous system function underlying comorbidities in IBS and their interaction with the peripheral microbiota-gut-brain axis. To identify biomarkers specific for prevention, diagnosis and therapy of comorbid and multi-comorbid IBS. N= 300 patients with IBS and multicomorbolities (Depression, Anixiety Duration: 4 years
  67. 67. Technological: -Data format -Quality of data -Common database/ open acces platform? Methodological: -Reliability and Feasability of the data Ethics -Committee of Ethics
  68. 68. ADDRESS c/Pascual i Vila, Barcelona, 08028, Spain (+34) 628994983 nuria.pastor @humanitcare.com
  69. 69. Presentations Dr. Christian Vogler CEO and Founder Advancience
  70. 70. Scalable Digital Diagnostics info@advancience.ch www.advancience.io @advancience Dr Christian Vogler CEO & CO-founder
  71. 71. Dementia is estimated to be the cause of 1/3 of wrong-way driving accidents Xing, J. (2015). Characteristics of wrong-way driving on motorways in Japan. In IET Intelligent Transport Systems (Vol. 9, pp. 3–11) Jalayer, et.al. (2018). Wrong-way driving crashes: A multiple correspondence approach to identify contributing factors. Traffic Injury Prevention, 19(1), 35–41.
  72. 72. The Problem Multi-layered Issues in Mental Health Diagnostics The Solution Game-based & Objective Measures of Cognition Enabling Objective Diagnostics Setting New Standards Using Scalable Digital Psychometrics 34© Advancience
  73. 73. Revolutionary & highly secure data privacy by design Novel, reliable & sensitive diagnostic tools Solid & structured data base ensuring fast & agile test development Game-based smart data acquisition Scalable diagnostics & treatment monitoring Cognitive World Atlas
  74. 74. Identifying Mental Health Markers
  75. 75. Quantifying Behavior & Cognition Attention Memory Reaction Time T1 T2 T3 T4 37 Game-based Assessment of Neurocognitive Functioning © Advancience
  76. 76. 38 The Value Of Cognitive Profiling Evaluating Treatment Success Concentration Span Vigilance Reasoning Working Memory Processing Speed Theory of Mind Social Cognition Learning Healthy Baseline Impacted Remission © Advancience
  77. 77. Memory Loss Difficulties in Contrast or Color Perception Difficulties in Concentration Difficulty in Planning and Solving Problems Difficulties in Making Decisions Cognition Time Onset Current Clinical Approach AD Diagnosis Detectable Cognitive Decline Fighting Dementia Early Tracking Mental Fitness Holds The Key For New Treatment Approaches 39© Advancience
  78. 78. 40 Time Cognition T 1 T 2 Frequency Of Testing Is Important © Advancience
  79. 79. Bringing Diagnostics Home • Novel tools • Objective • High-resolution • High-frequency • From home • Diagnosis • Monitoring • Clinical trials 41© Advancience
  80. 80. Thank You For Your Time info@advancience.ch www.advancience.io @advancience www.cognitiveworldatlas.com
  81. 81. Presentations Farina Schurzfeld CMO and Co-Founder Selfapy, Berlin
  82. 82. The #1 Digital Psychotherapy
  83. 83. headline: Trautmann et al., The economic costs of mental disorders, 2016 1: Jacobi F, Höfler M, Strehle J et al. (2016) Erratum zu: Psychische Störungen in der Allgemeinbevölkerung 2: Seattle, United States: Institute for Health Metrics and Evaluation (IHME), 2017. 3: Ärztezeitung, 2019, Doppelt so viele Fehltage wegen psychischer Störungen. 4: Statistisches Bundesamt, 2017 5: Faktencheck Depression Studie, 2014 17 million patients with mental health issues in Germany, one billon patients worldwide1,2 107 million sick days in Germany3 per year, leading to economic damage of > EUR 44 billion4 Health insurance companies spend > EUR 2.4005 per patient per year, yet relapse rates are high Poor patient experience due to >5 months waiting time for receiving treatment and analog user experience Unquantifiable amount of unnecessary human suffering due to stigmatization and inadequate treatment Problem One billion people in the world suffer from mental illnesses, creating > EUR 800 billion in cost for society
  84. 84. Combination of Same or better patient outcome compared to traditional therapy at 10% of the cost. leadsto Online classes, videos and audio files Interaction with trained psychologist via phone & chat Interactive digital app for mood tracking Solution I Selfapy has developed 12 week programs for combatting the mental illnesses of patients Depression Anxiety Stress Eating Disorder Trauma
  85. 85. Solution II Research has shown effectiveness of Selfapy therapies 10 15 20 25 30 Start Woche 2 Woche 4 Woche 6 Woche 8 Symptom reduction stress (TICS) N = 263 10 15 20 25 Start Woche 2 Woche 4 Woche 6 Woche 8 Woche 10Woche 12 Symptom reduction anxiety (BAI) N = 155 6 8 10 12 14 Start Woche 2 Woche 4 Woche 6 Woche 8 Woche 10 Woche 12 Symptom reduction depression (PHQ-9) N=151 Partners
  86. 86. Customer Acquisition I Selfapy uses above-the-line marketing leading to increasing awareness and market share gains in organic traffic TV Ads* Out-of-home Media Coverage Awards 70% 81% 87% 90% 92% 93% 94% 12% 8% 5% 4% 3% 3% 2% 5% 3% 2% 2% 1% 1% 1% 12% 8% 5% 4% 3% 3% 2% 0% 20% 40% 60% 80% 100% Feb 19 Mär 19 Apr 19 Mai 19 Jun 19 Jul 19 Aug 19 Traffic Market Share Selfapy Gaia/deprexis Geton Novego *Awarded EUR 3m media budget at SevenVentures Pitch Competiton > 90% traffic share with only EUR 10k monthly marketing Organic traffic of 73% Customer acquisition cost of 21€ > 35% conversion rate from signup to user
  87. 87. Customer Acquisition II Selfapy partners with health insurances to drive user numbers and revenue 1: 0,5% based on numbers of one insurance partner (SBK), with which we already reach 0,5% of all mentally ill per year 2: Currently low due to high negotiating power of insurances. New contracts starting in 2020 will be at an AOV of EUR 200. Potential to increase price further in 2020 to EUR 450 under the new DVG law. 3: Calculated at an average of 40€ in 2019 (status quo), and an average of 125€ from 2020. 4: Calculated at an account manager salary of 58.000€, assuming that an account managers can support 20 insurance partners (status quo) Economics insurance (B2B2C) 2019 Potential 2020 Number of insurances that reimburse Selfapy 16 23 Members of all insurance partners combined 15 mn 20 mn Members with mental illness 3 mn 4 mn Patients treated 5510 (0,18%) 7.942 (0,2%) AOV2 62 € 180 € Annual revenue 341.620 € 1,4 mn € Variable Cost3 195.000 € 0,9 mn € Cost of account management4 55.680 € 80.040 € Profit Contribution 90.940 € 419.960 € 6
  88. 88. Customer Acquisition II From 2020, all 17 million potential German patients will likely get Selfapy’s treatment fully covered by their insurance under Jens Spahn‘s new DVG legislation * 7
  89. 89. Competition Selfapy can be superior to traditional means of treatment at only 10% of the cost Selfapy Traditional Face-to-Face Therapy Duration 9-14 months Cost EUR 3.200 Effect Significant Online learning modules Conversation with psychologist Costs EUR 450 Effect Significant Duration 2-3 months
  90. 90. Team Strong team driven to improve the health care given to millions of people with mental disorders Advisory Team Farina Schurzfeld CMO Business degree Prev.: >10 Jahre Marketing, Sales und Founding Experience at Nevaly, Hitfox & Groupon Nora Blum CEO Psychologist with degree from University of Cambridge, Prev.: Rocket Internet, UKE-Klinikum Katrin Bermbach COO Psychologist with degree from International Psychoanalytic University, Prev.: Charité Stefan Rothlehner CTO Technical and business degree from TU Munich & CDTM Prev.: Co-Founder & CTO of Foodora, sold to Delivery Hero Dr. Paul Schmidt Charité Prof. Dr. Steffen Moritz Universitätsklinikum Hamburg- Eppendorf Dr. Petra Becker Geschäftsführerin der Dr. Becker Kliniken Prof. Dr. Sabine Steins-Löber Uni Bamberg Prof. Dr. med. Stephan Köhler Charité Prof. Dr. med. Philipp Sterzer Charité Prof. Dr. Stefan Röpke Charité Sabine Hahn Psych. Psychotherapeutin
  91. 91. Contact us! Farina Schurzfeld Farina@selfapy.com +49 163 6741 966
  92. 92. Presentations Bear O. O. Matthews Head of Public Relations Astra Labs, San Francisco
  93. 93. Panel Discussion Stefan Germann, CEO Fondation Botnar Gunther Meinlschmidt, University Hospital Basel Nuria Pastor Hernández, Humanitcare, Barcelona Christian Vogler, Advancience, Basel Farina Schurzfeld, Selfapy, Berlin Bear Matthews, Astra Labs, San Francisco
  94. 94. DayOne Agenda 2020 April 28th: Value based healthcare – the new industry standard? June 17th: MDR, GPR and Co. – how to navigate the regulatory landscape August 26th: Smart Prevention November 12th: DayOne Conference December 8th: Public Health
  95. 95. DayOne Experts, February 18th, Halle 7, Basel Measuring the Unmeasurable will digital pave the way for new treatments in mental health?

×